2019
Glucocorticoid Receptor-Deficient Foxp3(+) Regulatory T Cells Fail to Control Experimental Inflammatory Bowel Disease.
Rocamora-Reverte L,
Tuzlak S,
von Raffay L,
Tisch M,
Fiegl H,
Drach M,Reichardt HM,
Villunger A,
Tischner D,
Wiegers GJ.
Front Immunol. 2019 Mar 18;10:472. doi:10.3389/fimmu.2019.00472. eCollection 2019.
2019
Insights into the transport side of the human SLC38A9 transceptor.
Scalise M,
Galluccio M,
Pochini L,
Cosco J,
Trotta M,
Rebsamen M,Superti-Furga G,
Indiveri C.
Biochim Biophys Acta Biomembr. 2019 Jul 8;1861(9):1558-1567.doi: 10.1016/j.bbamem.2019.07.006. [Epub ahead of print]
2019
PD-L1 and PD1 expression in post-transplantation lymphoproliferative disease (PTLD) of childhood and adolescence: An inter- and intra-individual descriptive study covering the whole spectrum of PTLD categories.
Schiefer AI,
Salzer E,
Füreder A,
Szepfalusi Z,
Müller-Sacherer T,
Huber WD,
Michel-Behnke I,
Lawitschka A,
Pichler H,
Mann G,
Hutter C,
Simonitsch-Klupp I,Attarbaschi A.
Cancer Med. 2019 Jul 3. doi: 10.1002/cam4.2394. [Epub ahead of print]
2019
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms.
Schischlik F,
Jäger R,
Rosebrock F,
Hug E,
Schuster M,
Holly R,
Fuchs E,Milosevic Feenstra JD,
Bogner E,
Gisslinger B,
Schalling M,
Rumi E,
Pietra D,Fischer G,
Faé I,
Vulliard L,
Menche J,
Haferlach T,
Meggendorfer M,
Stengel A,Bock C,
Cazzola M,
Gisslinger H,
Kralovics R.
Blood. 2019 Jul 11;134(2):199-210. doi: 10.1182/blood.2019000519. Epub2019 May 7.
2019
Combined chemosensitivity and chromatin profiling prioritizes drug combinations in CLL.
Schmidl C,
Vladimer GI,
Rendeiro AF,
Schnabl S,
Krausgruber T,
Taubert C,Krall N,
Pemovska T,
Araghi M,
Snijder B,
Hubmann R,
Ringler A,
Runggatscher K,Demirtas D,
de la Fuente OL,
Hilgarth M,
Skrabs C,
Porpaczy E,
Gruber M,
HoermannG,
Kubicek S,
Staber PB,
Shehata M,
Superti-Furga G,
Jäger U,
Bock C.
Nat Chem Biol. 2019 Mar;15(3):232-240. doi: 10.1038/s41589-018-0205-2. Epub 2019 Jan 28.
2019
TET enzymes control antibody production and shape the mutational landscape in germinal centre B cells.
Schoeler K,
Aufschnaiter A,
Messner S,
Derudder E,
Herzog S,
Villunger A,Rajewsky K,
Labi V.
FEBS J. 2019 May 23. doi:10.1111/febs.14934. [Epub ahead of print]
2019
CHK1 dosage in germinal center B cells controls humoral immunity.
Schoeler K,
Jakic B,
Heppke J,
Soratroi C,
Aufschnaiter A,
Hermann-Kleiter N,Villunger A,
Labi V.
Cell Death Differ. 2019 Mar 20. doi: 10.1038/s41418-019-0318-5. [Epubahead of print]
2019
Impact of farnesoid X receptor single nucleotide polymorphisms on hepatic decompensation and mortality in cirrhotic patients with portal hypertension.
Semmler G,
Simbrunner B,
Scheiner B,
Schwabl P,
Paternostro R,
Bucsics T,Stättermayer AF,
Bauer D,
Pinter M,
Ferenci P,
Trauner M,
Mandorfer M,
Reiberger T.
JGastroenterol Hepatol. 2019 May 6. doi: 10.1111/jgh.14700. [Epub ahead of print]
2019
Human DEF6 deficiency underlies an immunodeficiency syndrome with systemic autoimmunity and aberrant CTLA-4 homeostasis.
Serwas NK,
Hoeger B,
Ardy RC,
Stulz SV,
Sui Z,
Memaran N,
Meeths M,
Krolo A,
Yüce Petronczki Ö,
Pfajfer L,
Hou TZ,
Halliday N,
Santos-Valente E,
Kalinichenko A,
Kennedy A,
Mace EM,
Mukherjee M,
Tesi B,
Schrempf A,
Loizou JI,
Kain R,Bidmon-Fliegenschnee B,
Schickel JN,
Glauzy S,
Huemer J,
Garncarz W,
Salzer E,Pierides I,
Bilic I,
Thiel J,
Priftakis P,
Banerjee PP,
Förster-Waldl E,
MedgyesiD,
Huber WD,
Orange JS,
Meffre E,
Sansom DM,
Bryceson YT,
Altman A,
Boztug K.
Nat Commun. 2019 Jul 15;10(1):3106.doi: 10.1038/s41467-019-10812-x.
2019
A Novel Recessive Mutation of Interferon-γ Receptor 1 in a Patient with Mycobacterium tuberculosis in Bone Marrow Aspirate.
Shabani M,
Aleyasin S,
Kashef S,
Zoghi S,
Deswarte C,
Casanova JL,
BustamanteJ,
Rezaei N.
J Clin Immunol. 2019Feb;39(2):127-130. doi: 10.1007/s10875-019-00595-7. Epub 2019 Feb 5.
